Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Pathways’ Picks August 3: Medicare and Medtech, EU Picks, and More

In this week’s roundup: CMS addresses new medtech in its inpatient payment rule; AdvaMed wants action on a novel tech coverage pathway; a new notified body and more EU MDR and IVDR updates; EPA eyes EtO; Medicare Advantage input sought; 3D-printing oversight, and updates from Brazil and Eurasia.

Start a free trial and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Perspective & Commentary

Market Pathways Top 5 June 2022

The top five Market Pathways articles posted in June to MyStrategist.com, chosen by readers and editors, include EU pressure to amp up MDR compliance, Innara's strategy to avoid capex constraints, Senate encouragement of PCCP use, and two of our recurring columns: Pathways' Picks and Pathways' Document Depot.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More